Home Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.
 

Keywords :   


Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.

2016-03-30 03:53:43| drugdiscoveryonline Home Page

Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases

Tags: acquire therapeutics squibb padlock

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »